Click here to search courses using NAPNAP's previous Course Catalog layout.
Title
Category
Credits
Event date
Cost
- Primary Care
- Acute Care
- FREE for Members
- Human Trafficking
- 1.50 Contact hours
$0.00
This course is not accredited by NAPNAP. This course is approved by Texas Health and Human Services to meet the requirements of H.B. 2059.
Providers must register for a free PedsCE account, and be logged in to watch the webinar and receive the certificate.
This course was created in collaboration with Partners for Vulnerable Youth.
- Primary Care
- Acute Care
- Pharmacology CE
$145.00
8.25 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $65 for NAPNAP Members. For non- members, this continuing education activity rate is $145. Current pediatric prescribing recommendations will be reviewed. An extensive review and update will provide the participant with an improved understanding of therapeutic benefits, as well as potential risks of medications prescribed for children, including efficacy, safety and prescribing recommendations. Drugs abused by adolescents, nutraceuticals used with children, updates on treatment guidelines and changes in drug labeling, as well as dermatology will be also reviewed.
- Primary Care
- Acute Care
- Pharmacology CE
- 1.00 Contact hours
$20.00
1.00 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. This presentation will focus on medications commonly prescribed for dermatology conditions such as atopic dermatitis, psoriasis, skin infections and infestations, acne, molluscum and warts. Learners will gain a knowledge of common treatments and applicable clinical judgement skills to choose optimal medication treatment options for our patients.
- Primary Care
- Acute Care
- Infectious Disease
- Pharmacology CE
- 1.00 Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. Current information from CDC will be reviewed. Most current information about vaccine safety will also be covered.
- Primary Care
- Acute Care
- Pharmacology CE
- 1.00 Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. An extensive review will provide the participant with up-to-date information pharmacological management of common respiratory illnesses in children.
- Primary Care
- Acute Care
- Pharmacology CE
- 1.00 Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. An extensive review will provide an up‐to‐date information on current recommendations for use of GI drugs in the pharmacological management of common GI pathologies in children.
- Primary Care
- Acute Care
- Pharmacology CE
- 1.00 Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. This module will introduce nutraceuticals and review common pediatric uses for nutraceuticals.
- Primary Care
- Pharmacology CE
- 1.00 Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. Penicillin allergy, the most commonly reported allergy in a pediatric patient, is associated with increases in cost of care, hospitalization and morbidity, as well as contributing to antibiotic resistance. However, 95% of patients labeled with a penicillin allergy do not have a true allergy. The Centers for Disease Control & Prevention has identified improper use of antibiotics to be an important factor that must be addressed for both patient safety and public health. This presentation will identify high-risk symptoms of allergy, differentiate between adverse reactions, IgE-mediated allergic reaction and delayed T-cell reactions, as well as discuss appropriate testing for penicillin allergy. Additionally, the presenter will address alternative antibiotics that can be used until a formal allergy evaluation can be completed.
- Primary Care
- Acute Care
- Infectious Disease
- Pharmacology CE
- 1.25 Contact hours
$25.00
1.25 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12 for NAPNAP Members. For non- members, this continuing education activity rate is $25.
This presentation will discuss prescribing for pediatric patients in light of spotlights on inappropriate antibiotic prescribing. A rapid review of current guidelines for treating pediatric infectious diseases will frame a discussion on how to incorporate guidelines into daily practice. Local and national resistance patterns will be discussed, as well as adverse effects of antibiotics including rising resistance and C. difficile rates.
- Primary Care
- Acute Care
- Pharmacology
- 1.00 Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. Current pediatric prescribing recommendations will be reviewed. An extensive review and update will provide the participant with an improved understanding of therapeutic benefits as well as potential risks of medications prescribed for children, including efficacy, safety and prescribing recommendations. Current MedWatch Safety Alerts issued by the FDA will also be covered.